medline.ch Onkologie Urologische Tumoren

	Recent Advances in Cyclic Peptide-Based Therapeutic Strategies for Renal Cell Carcinoma: A Focused Review. Drug Des Devel Ther Sun L, Li X, Liu Y, Wu G. PMID: 42829760 [PubMed - indexed for MEDLINE]
	Re: Sobia Khan, Nathan Papa, Andrew Kneebone, et al. Prospective Comparison of (64)Copper [(64)Cu]SAR-bisPSMA vs (68)Gallium [(68)Ga] PSMA-11 PET/CT for Biochemical Recurrence of Prostate Cancer Following Radical Prostatectomy (Co-PSMA Trial). Eur Urol 2026;89:512-20. Eur Urol Hindié E, Callaud A, Morgat C. PMID: 42829270 [PubMed - as supplied by publisher]
	Reply to Paolo Zaurito's Letter to the Editor re: Robert M. Meier, Nima Aghdam, Alan C. Beckman, et al. 10-yr Survival and Toxicity Outcomes of Stereotactic Body Radiotherapy for Prostate Cancer: A Nonrandomized Clinical Trial. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2026.04.029. Eur Urol Meier R, Aghdam N, Kaplan I. PMID: 42829268 [PubMed - as supplied by publisher]
	Reply to Riccardo Lombardo's Letter to the Editor re: Bi-Ming He, Keqin Zhang, Zhien Zhou, et al. Cognitive Versus Software-based Fusion targeted Biopsy for the Diagnosis of Clinically Significant Prostate Cancer: A Multicenter, Randomized, Noninferiority Trial (IMAGINATION). Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2026.06.020. Eur Urol He BM, Wang HF. PMID: 42829267 [PubMed - as supplied by publisher]
	PSMA-PET/CT-guided Intensification of Radiation Therapy for Prostate Cancer (PSMAgRT): 5-yr Analysis of a Phase 2 Randomized Controlled Trial. Eur Urol Belliveau C, Saad F, Duplan D, Petit C, Delouya G, Lambert C, Taussky D, Barkati M, Beauchemin MC, Clavel S, Mok G, Gauthier-Paré AS, Igidbashian L, Jolicoeur M, Nguyen TV, McLaughlin PY, Wong P, Keu KV, DaSilva JN, Juneau D, Ménard C. PMID: 42829266 [PubMed - as supplied by publisher]
	Re: Microultrasonography-guided Versus MRI-guided Biopsy for Prostate Cancer Diagnosis: The OPTIMUM Randomized Clinical Trial. Eur Urol Girometti R, Giganti F. PMID: 42829264 [PubMed - as supplied by publisher]
	Diagnostic accuracy of (18)F-PSMA-1007 PET/CT and bone scintigraphy for detecting bone metastases in prostate cancer. Jpn J Radiol Kitajima K, Naka S, Hatano K, Uemura M, Sasaki H, Kamiya T, Kurimoto K, Katayama D, Kato H, Liu Y, Cardinale J, Giesel FL, Nonomura N, Watabe T. PMID: 42828696 [PubMed - as supplied by publisher]
	Oncological outcomes after Senhance robot-assisted radical prostatectomy: biochemical recurrence and risk stratification in a large single-centre cohort. J Robot Surg Zekulic T, Kulis T, Hudolin T, Penezic L, Andelic J, Sambolic T, Saric D, Knezevic N, Kastelan Z. PMID: 42828655 [PubMed - indexed for MEDLINE]
	Robot-assisted versus non-robotic partial nephrectomy for completely endophytic renal tumors: a systematic review and meta-analysis. J Robot Surg Yang JW, Wang L, Chen HM, Chen SY, Yang L. PMID: 42828586 [PubMed - indexed for MEDLINE]
	Prevalence of osteoporosis and low bone mass in men with prostate cancer: a systematic review and meta-analysis. Support Care Cancer Ebrahimi M, Mohammadi A, Sarmadi S, Rahimnia R, Zare-Kaseb A, Reis LO, Shabestari AN, Sanaie N, Keshtkar A, Aghamir SMK. PMID: 42828578 [PubMed - indexed for MEDLINE]
	Impact of magnetic resonance imaging-based diagnostic pathway on oncologic outcomes of localised prostate cancer between primary treatment modalities: a Will-Rogers phenomenon? World J Urol Yu L, Lee HJ, Lee AY, Goh JL, Tay KJ, Ho HSS, Tuan J, Yuen JSP, Chen K. PMID: 42828553 [PubMed - indexed for MEDLINE]
	PSMA PET/CT Kinetics During Systemic Therapy and Radiotherapy in Hormone-sensitive Prostate Cancer: A Systematic Review. Eur Urol Open Sci Le Guévelou J, Bauckneht M, Soeterik TFW, Scheltema M, Bianchi L, Kesch C, Gandaglia G, Rajwa P, Nicoletti R, Zattoni F, Martini A, Fasulo V, Kasivisvanathan V, Preisser F, Sanchez LR, Ambrosini F, Falagario U, Fazekas T, Giesen A, Rovera G, Maggi M, Mercinelli C, Miszczyk M, Rivas JG, Windisch O, Stroomberg H, Rui B, Bourgi A, Tilki D, Marra G, EAU-YAU Prostate Cancer Working Group. PMID: 42828270 [PubMed]
	Patient-derived prostate cancer organoids: model development, therapeutic applications, and challenges for precision oncology. Front Oncol Zhu J, Wang S, Du F, Shao S. PMID: 42827781 [PubMed]
	The cost-effectiveness of medical versus surgical androgen deprivation therapy for advanced prostate cancer in Tanzania: a Markov model-based analysis. Front Public Health Nyongole O, Tungu M, Kagaigai A, Anaeli A, Tindamanyile A, Njau P, Mizinduko M, Urassa D, Sunguya B, Frumence G. PMID: 42827560 [PubMed - indexed for MEDLINE]
	Exploring regulated cell death in renal cell carcinoma: mechanistic insights and therapeutic perspectives. Apoptosis Zhu G, Zhang H, Li Y, Ma W, Yao Y, Lyu D, Lu B, Zong Y, Dong K, Zhou W, Liu Y, Cui X, Pan X. PMID: 42829358 [PubMed - indexed for MEDLINE]
	Radiomic model versus R.E.N.A.L. nephrometry score for predicting the likelihood of undergoing partial nephrectomy in clear cell renal cell carcinoma. Front Urol Liu FD, Yu HL, Wang DJ, Ju XB, Yang YH. PMID: 42827468 [PubMed]
	Imaging in Upper Tract Urothelial Carcinoma: Diagnostic Accuracy of Current Modalities for Local Tumor Staging. Curr Urol Rep Dudinec JV, Tan YG, Refugia JM, Nabavizadeh R, Shah AM, Abern MR, Ghoreifi A. PMID: 42825969 [PubMed - indexed for MEDLINE]
	Correction to: Prevalence of meeting aerobic physical activity and resistance training guidelines in advanced prostate cancer: a descriptive study of racial and regional disparities in the IRONMAN registry. Support Care Cancer Solberg A, Grydeland M, Nilsen TS, Storås AH, Davis ID, Greaves N, Anderson S, Fay AP, Chi KN, Enting D, McDermott R, Badal S, Waihenya CG, Popoola A, Lazarus JM, Mateo J, Bjartell A, Omlin A, Odedina F, Ragin C, Mucci LA, IRONMAN investigators, Russnes KM. PMID: 42825937 [PubMed - in process]
	Sexual and relational challenges in men and women affected by prostate cancer: a Project SEXUS study. BJU Int Lundorff IJ, Graugaard C, Fode M, Andersson M, Frisch M. PMID: 42825355 [PubMed - as supplied by publisher]
	Mechanisms of microbiome-immune interactions in bladder cancer and targeted regulatory strategies. Front Immunol Wu S, Fu S, Shi H, Gong Y, Chen P, Zhang X, Jiang E, Wang H. PMID: 42824830 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 181928

Seite 1 von 9097

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung